BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tonus C, Neupert G, Sellinger M. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J Gastroenterol 2006; 12(43): 7007-7011 [PMID: 17109496 DOI: 10.3748/wjg.v12.i43.7007]
URL: https://www.wjgnet.com/1007-9327/full/v12/i43/7007.htm
Number Citing Articles
1
M V Kruchinina, A A Gromov, Y I Prudnikova, V M Generalov, V N Kruchinin, V A Volodin, G V Shuvalov, O V Minin, S V Shehovtsov, S E Peltec, I V Minin. Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancerIOP Conference Series: Materials Science and Engineering 2019; 516: 012017 doi: 10.1088/1757-899X/516/1/012017
2
Hamid Kalantari, Mahsa Khodadoostan, Majid Yaran, Abdolrasoul Tavakoli. Diagnostic value of pyruvate kinase isoenzyme type M2 in colon cancer proven with colonoscopyAdvanced Biomedical Research 2020; 9(1): 76 doi: 10.4103/abr.abr_91_20
3
Suresh Sithambaram, Ida Hilmi, Khean-Lee Goh, Lanjing Zhang. The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal CancerPLOS ONE 2015; 10(7): e0131616 doi: 10.1371/journal.pone.0131616
4
Sybille Mazurek. Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cellsThe International Journal of Biochemistry & Cell Biology 2011; 43(7): 969 doi: 10.1016/j.biocel.2010.02.005
5
Xiufeng Liu, Zhenhu Chen. Proceedings of the International Conference on Information Engineering and Applications (IEA) 2012Lecture Notes in Electrical Engineering 2013; 216: 265 doi: 10.1007/978-1-4471-4856-2_33
6
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test? 1LaboratoriumsMedizin 2008; 32(3): - doi: 10.1515/JLM.2008.021et
7
Shilpa Joshi, Stephen J Lewis, Siobhan Creanor, Ruth M Ayling. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2010; 47(3): 259 doi: 10.1258/acb.2009.009061
8
Young S. Kim, Padma Maruvada. Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshopMetabolomics 2008; 4(2): 105 doi: 10.1007/s11306-008-0109-3
9
Sandra Tan, Cynthia R. M. Y. Liang, Khay Guan Yeoh, Jimmy So, Choy Leong Hew, Maxey C. M. Chung. Gastrointestinal fluids proteomicsPROTEOMICS – CLINICAL APPLICATIONS 2007; 1(8): 820 doi: 10.1002/prca.200700169
10
Ruth M Ayling. New faecal tests in gastroenterologyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2012; 49(1): 44 doi: 10.1258/acb.2011.011150
11
K. F. Newton, W. Newman, J. Hill. Review of biomarkers in colorectal cancerColorectal Disease 2012; 14(1): 3 doi: 10.1111/j.1463-1318.2010.02439.x
12
Yogesh M. Shastri, Stefan Loitsch, Nicolas Hoepffner, Nada Povse, Ernst Hanisch, Wolfgang Rösch, Joachim Mössner, Jürgen M. Stein. Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter StudyThe American Journal of Gastroenterology 2008; 103(6): 1496 doi: 10.1111/j.1572-0241.2008.01824.x
13
Philip D Hardt, Nils Ewald. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancyExpert Review of Molecular Diagnostics 2008; 8(5): 579 doi: 10.1586/14737159.8.5.579
14
A. Loganayagam. Faecal screening of colorectal cancerInternational Journal of Clinical Practice 2007; 62(3): 454 doi: 10.1111/j.1742-1241.2007.01532.x
15
Sarah Strohkamp, Timo Gemoll, Sina Humborg, Sonja Hartwig, Stefan Lehr, Sandra Freitag-Wolf, Susanne Becker, Bo Franzén, Ralph Pries, Barbara Wollenberg, Uwe J. Roblick, Hans-Peter Bruch, Tobias Keck, Gert Auer, Jens K. Habermann. Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancerCellular and Molecular Life Sciences 2018; 75(2): 323 doi: 10.1007/s00018-017-2631-9
16
Jasmina Saric, Yulan Wang, Jia Li, Muireann Coen, Jürg Utzinger, Julian R. Marchesi, Jennifer Keiser, Kirill Veselkov, John C. Lindon, Jeremy K. Nicholson, Elaine Holmes. Species Variation in the Fecal Metabolome Gives Insight into Differential Gastrointestinal FunctionJournal of Proteome Research 2008; 7(1): 352 doi: 10.1021/pr070340k
17
Wen Meng, Hong-Hong Zhu, Ze-Feng Xu, Shan-Rong Cai, Qi Dong, Qiang-Rong Pan, Shu Zheng, Su-Zhan Zhang. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screeningWorld Journal of Gastrointestinal Oncology 2012; 4(6): 145-151 doi: 10.4251/wjgo.v4.i6.145
18
Ashley Bond, Rosemary Greenwood, Stephen Lewis, Bernard Corfe, Sanchoy Sarkar, Paul O'Toole, Paul Rooney, Michael Burkitt, Georgina Hold, Chris Probert. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancerAlimentary Pharmacology & Therapeutics 2019; 49(8): 1005 doi: 10.1111/apt.15140
19
Harsha R. Hathurusinghe, Kolitha S. Goonetilleke, Ajith K. Siriwardena. Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal MalignancyAnnals of Surgical Oncology 2007; 14(10): 2714 doi: 10.1245/s10434-007-9481-x
20
Jinny Jeffery, Stephen J. Lewis, Ruth M. Ayling. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disordersInflammatory Bowel Diseases 2009; 15(11): 1630 doi: 10.1002/ibd.20946
21
J.-M. Träder. Facharztprüfung Allgemeinmedizin2013; : 317 doi: 10.1016/B978-3-437-23323-4.00014-6
22
Judith YMN Derijks-Engwegen, Annemieke Cats, Marianne E Smits, Jan HM Schellens, Jos H Beijnen. Improving colorectal cancer management: the potential of proteomicsBiomarkers in Medicine 2008; 2(3): 253 doi: 10.2217/17520363.2.3.253
23
Ching-Seng Ang, Julie Rothacker, Heather Patsiouras, Antony W. Burgess, Edouard C. Nice. Murine fecal proteomics: A model system for the detection of potential biomarkers for colorectal cancerJournal of Chromatography A 2010; 1217(19): 3330 doi: 10.1016/j.chroma.2009.10.007
24
Aslı Hapa, Gül Erkin, Gülşen Hasçelik, Dilara Pektaş, Umut Arslan. Plasma TM2-PK levels in mycosis fungoides patientsArchives of Dermatological Research 2011; 303(1): 35 doi: 10.1007/s00403-010-1085-9
25
Ching-Seng Ang, Jason Phung, Edouard C. Nice. The discovery and validation of colorectal cancer biomarkersBiomedical Chromatography 2011; 25(1-2): 82 doi: 10.1002/bmc.1528
26
Banafsheh Zeinali-Rafsanjani, Reza jalli, Mahdi Saeedi-Moghadam, Parisa Pishdad. Magnetic resonance spectroscopy and its application in colorectal cancer diagnosis and screening: A narrative reviewJournal of Medical Imaging and Radiation Sciences 2020; 51(4): 654 doi: 10.1016/j.jmir.2020.07.004
27
Melissa Oliveira-Cunha, Ajith K. Siriwardena, Richard Byers. Molecular diagnosis in pancreatic cancerDiagnostic Histopathology 2008; 14(5): 214 doi: 10.1016/j.mpdhp.2008.03.004
28
Rui Li, Jianjun Liu, Huiping Xue, Gang Huang. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: A systematic review and meta-analysisInternational Journal of Cancer 2012; 131(8): 1837 doi: 10.1002/ijc.27442
29
Fabrizio Parente, Barbara Marino, Antonina Ilardo, Pierluigi Fracasso, Angelo Zullo, Casare Hassan, Roberto Moretti, Marco Cremaschini, Antonio Ardizzoia, Ilaria Saracino, Federico Perna, Dino Vaira. A combination of faecal tests for the detection of colon cancerEuropean Journal of Gastroenterology & Hepatology 2012; 24(10): 1145 doi: 10.1097/MEG.0b013e328355cc79
30
Reena Shah, Emma Jones, Victoire Vidart, Peter J.K. Kuppen, John A. Conti, Nader K. Francis. Biomarkers for Early Detection of Colorectal Cancer and Polyps: Systematic ReviewCancer Epidemiology Biomarkers & Prevention 2014; 23(9): 1712 doi: 10.1158/1055-9965.EPI-14-0412
31
J.-M. Träder. Facharztprüfung Allgemeinmedizin2017; : 323 doi: 10.1016/B978-3-437-23325-8.00014-2
32
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. Early detection of colorectal cancer: from conventional methods to novel biomarkersJournal of Cancer Research and Clinical Oncology 2016; 142(2): 341 doi: 10.1007/s00432-015-1928-z
33
Jill Tinmouth, Emily T. Vella, Nancy N. Baxter, Catherine Dubé, Michael Gould, Amanda Hey, Nofisat Ismaila, Bronwen R. McCurdy, Lawrence Paszat. Colorectal Cancer Screening in Average Risk Populations: Evidence SummaryCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/2878149
34
U Haug, S Hundt, H Brenner. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening studyBritish Journal of Cancer 2008; 99(1): 133 doi: 10.1038/sj.bjc.6604427
35
Yong Cheol Kim, Jeong Ho Kim, Dae Young Cheung, Tae Ho Kim, Eun Jung Jun, Jung-Whan Oh, Chang Whan Kim, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim, Jin Il Kim, Soo-Heon Park, Jae Kwang Kim. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase TestGut and Liver 2015; 9(5) doi: 10.5009/gnl13457
36
Mallikarjuna Uppara, Franklin Adaba, Alan Askari, Susan Clark, George Hanna, Thanos Athanasiou, Omar Faiz. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancerWorld Journal of Surgical Oncology 2015; 13(1): 48 doi: 10.1186/s12957-015-0446-4
37
Yoshikatsu Koga, Nobuyoshi Yamazaki, Yasuhiro Matsumura. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNAExpert Review of Molecular Diagnostics 2014; 14(1): 107 doi: 10.1586/14737159.2014.863152
38
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Nicht-invasive Diagnostik kolorektaler Tumore – Hat der Guaiac-Test ausgedient? / Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?LaboratoriumsMedizin 2008; 32(3): 158 doi: 10.1515/JLM.2008.021